1. Home
  2. MRUS vs INTR Comparison

MRUS vs INTR Comparison

Compare MRUS & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • INTR
  • Stock Information
  • Founded
  • MRUS 2003
  • INTR 1994
  • Country
  • MRUS Netherlands
  • INTR Brazil
  • Employees
  • MRUS N/A
  • INTR N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • INTR
  • Sector
  • MRUS Health Care
  • INTR
  • Exchange
  • MRUS Nasdaq
  • INTR Nasdaq
  • Market Cap
  • MRUS 2.7B
  • INTR 3.1B
  • IPO Year
  • MRUS 2016
  • INTR N/A
  • Fundamental
  • Price
  • MRUS $56.07
  • INTR $7.12
  • Analyst Decision
  • MRUS Strong Buy
  • INTR Buy
  • Analyst Count
  • MRUS 15
  • INTR 3
  • Target Price
  • MRUS $88.87
  • INTR $5.97
  • AVG Volume (30 Days)
  • MRUS 1.6M
  • INTR 2.8M
  • Earning Date
  • MRUS 05-07-2025
  • INTR 05-12-2025
  • Dividend Yield
  • MRUS N/A
  • INTR 1.12%
  • EPS Growth
  • MRUS N/A
  • INTR 97.58
  • EPS
  • MRUS N/A
  • INTR 0.40
  • Revenue
  • MRUS $54,732,000.00
  • INTR $860,720,325.00
  • Revenue This Year
  • MRUS $39.00
  • INTR $80.02
  • Revenue Next Year
  • MRUS $7.48
  • INTR $17.50
  • P/E Ratio
  • MRUS N/A
  • INTR $17.86
  • Revenue Growth
  • MRUS 42.77
  • INTR 39.90
  • 52 Week Low
  • MRUS $33.19
  • INTR $3.88
  • 52 Week High
  • MRUS $61.28
  • INTR $7.84
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 66.86
  • INTR 61.21
  • Support Level
  • MRUS $49.46
  • INTR $6.78
  • Resistance Level
  • MRUS $56.74
  • INTR $7.38
  • Average True Range (ATR)
  • MRUS 3.37
  • INTR 0.25
  • MACD
  • MRUS 1.57
  • INTR -0.02
  • Stochastic Oscillator
  • MRUS 91.31
  • INTR 62.86

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About INTR Inter & Co. Inc.

Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.

Share on Social Networks: